Genome wide expression analysis in HPV16 Cervical Cancer: Identification of altered metabolic pathways

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Pérez Plasencia, Carlos ^a   Vázquez Ortiz, Guelaguetza ^b   López Romero, Ricardo ^c   Piña Sanchez, Patricia ^b   Moreno, José ^c   Salcedo, Mauricio ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b Laboratorio de Oncología Genómica   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35348941842     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-16     Document Type: Article

References (53)

1. Munoz N, Xavier Bosch F: Cervical cancer and human papillomavirus: epidemiological evidence and perspectives for prevention. Salud Publica Mex 1997, 39:274-282.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah K, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87:796-802.
4. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
5. Boyer SN, Wazer DE, Band V: E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 1996, 56:4620-4.
6. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL: Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20:7888-7898.
7. Rapp L, Chen JJ: The papillomavirus E6 proteins. Biochim Biophys Acta 1998, 1378:F1-F19.
8. Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ: The human papillomavirus type 16 E7 gene product interacts with and trans-activates the API family of transcription factors. EMBO J 1996, 15:1950-1960.
9. Prathapam T, Kuhne C, Banks L: The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity. Oncogene 2001, 20:7677-7685.
10. Duensing S, Munger K: The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 2002, 62:7075-7082.
11. Brown P, Botstein R: Exploring the new world of the genome with DNA microarrays. Nature Genet 1999:33-37.
12. Young RA: Biomedical discovery with DNA arrays. Cell 2000, 102:9-15.
13. Lochart DJ, Winzeler EA: Genomics, gene expression and DNA arrays. Nature 2000, 405:827-836.
14. Ruutu M, Peitsaro P, Johansson B, Syrjanen S: Transcriptional profiling of a human papillomavirus 33-positive squamous epithelial cell line which acquired a selective growth advantage after viral integration. Int J Cancer 2002, 100:318-326.
15. Duffy CL, Phillips SL, Klingelhutz AJ: Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virol 2003, 314:196-205.
16. Thomas JT, Oh ST, Terhune SS, Laimins LA: Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J Virol 2001, 75:7564-7571.
17. Garner-Hamrick PA, Fostel JM, Chien WM, Banerjee NS, Chow LT, Broker TR, Fisher C: Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. J Virol 2004, 78:9041-9050.
18. Toussaint-Smith E, Donner DB, Roman A: Expression of human papillomavirus type 16 E6, E7 oncoproteins in primary fore-skin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene 2004, 23:2988-2995.
19. Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD: Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated, NF-kappaB-responsive genes in cervical keratinocytes. J Virol 2001, 75:4283-4296.
20. Shim C, Zhang, Hun C, Lee: Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 1998, 4:3045-3050.
21. Nees M, van Wijngaarden E, Bakos E, Schneider A, Durst M: Identification of novel molecular markers which correlate with HPV induced tumor progression. Oncogene 1998, 16:2447-58.
22. Chen Y, Miller C, Mosher R, Zhao X, Deeds J, Morrissey M, Bryant B, Yang D, Meyer R, Cronin F, Gostout BS, Smith-McCune K, Schlegel R: Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res 2003, 63:1927-1935.
23. Vazquez-Ortiz G, Pina-Sanchez P, Vazquez K, Duenas A, Taja L, Mendoza P, Garcia JA, Salcedo M: Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer 2005, 5:68.
24. Giles HG, vas Es JH, Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochem Biophys Acta 2003, 1653:1-24.
25. Logan CY, Nusse R: The wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
26. Ramakrishnan R, Dorris D, Lublinsky A, Nguyen A, Domanus M, Prokhorova A, Gieser L, Touma E, Lockner R, Tata M, Zhu X, Patterson M, Shippy R, Sendera TJ, Mazumder A: An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. Nucleic Acids Res 2002, 30:e30.
27. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121.
28. Khatri P, Sellamuthu S, Malhotra P, Amin K, Done A, Draghici S: Recent additions and improvements to the Onto-Tools. Nucleic Acids Res 2005, 33:W762-W765.
29. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997, 57:3935-3940.
30. Seidler H, Utsuyama M, Nagoka S, Takernura T, Kitagawa M, ad Hirokawa K: Expression of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups. Exp Mol Pathol 2004, 76:224-233.
31. Ebert MP, Yu J, Hoffmann J, Rocco A, Rocken C, Kahmann S, Muller O, Korc M, Sung JJ, Malfertheiner P: Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol 2003, 21:1708-1714.
32. Rodriguez-Sastre MA, Gonzalez-Maya L, Delgado R, Lizano M, Tsubaki G, Mohar A, Garcia-Carranca A: Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol 2005, 97:330-336.
33. Chung EJ, Sung YK, Farooq M, Kim Y, Im S, Tak WY, Hwang YJ, Kim Yl, Han HS, Kim JC, Kim MK: Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cells 2002, 14:382-387.
34. Rodriguez-Sastre MA, Gonzalez-Maya L, Delgado R, Lizano M, Tsubaki G, Mohar A, Garcia-Carranca: Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol 2005, 97:330-336.
35. Ocadiz R, Sauceda R, Cruz M, Graef AM, Gariglio P: High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Res 1987, 47:4173-7.
36. Agnantis NJ, Spandidos DA, Mahera H, Parissi P, Kakkanas A, Pintzas A, Papacharalampous NX: Immunohistochemical study of ras oncogene expression in endometrial and cervical human lesions. Eur J Gynaecol Oncol 1988, 9:360-365.
37. Cheung TH, Leung JO, Chung TK, Lam SK, To KF, Wong YF: c-fos overexpression is associated with the pathoneogenesis of invasive cervical cancer. Gynecol Obstet Invest 1997, 43:200-3.
38. Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D: NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 2003, 22:50-58.
39. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M: The KEGG resource for deciphering the genome. Nucleic Acids Res 2004, 32:D277-D280.
40. Milovanovic T, Planutis K, Nguyen A, Marsh JL, Lin F, Hope C, Holcombe RF: Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol 2004, 5:1337-1342.
41. Milovanovic T, Planutis K, Nguyen A, Marsh JL, Lin F, Hope C, Holcombe RF: Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol 2004, 5:1337-1342.
42. Roberts AB, Wakefield LM: The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci USA 2003, 100:8621-8623.
43. Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, Androphy E, Woodworth CD: Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Cancer Res 2000, 60:4289-98.
44. Lee DK, Kim BC, Kim IY, Cho EA, Satterwhite DJ, Kim SJ: The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence. J Biol Chem 2002, 277:38557-38564.
45. Maliekal TT, Antony ML, Nair A, Paulmurugan R, Karunagaran D: Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer. Oncogene 2003, 22:4889-4897.
46. Maki A, Berezesky IK, Fargnoli J, Holbrook NJ, Trump BF: Role of [Ca2+]i in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB J 1992, 6:919-924.
47. Trump BF, Berezesky IK: The role of cytosolic Ca2+ in cell injury, necrosis and apoptosis. Curr Opin Cell Biol 1992, 4:227-232.
48. Patterson RL, Boehning D, Snyder SH: Inositol 1,4,5-trisphosphate receptors as signal integrators, Annu Rev Biochem 73:437-465.
49. Shen M, Chou CY, Browning JA, Wilkins RJ, Elloryl JC: Human cervical cancer cells use Ca2+ signalling, protein tyrosine phosphorylation and MAP kinase in regulatory volume decrease. J Physiol 2001, 537:347-362.
50. Sakakura C, Hagiwara A, Fukuda K, Shimomura K, Takagi T, Kin S, Nakase Y, Fujiyama J, Mikoshiba K, Okazaki Y, Yamagishi H: Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers. Anticancer Res 2003, 23:3691-3697.
51. Bose DD, Rahimian R, Thomas DW: Activation of ryanodine receptors induces calcium influx in a neuroblastoma cell line lacking calcium influx factor activity. Biochem J 2005, 386:291-296.
52. Hidalgo A, Piña P, Guerrero G, Salcedo M: A simple method for the construction of small format tissue array. J Clin Pathol 2003, 56:144-146.
53. Terris MK, Peel DM: Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urol 1997, 50:150-156.